| Literature DB >> 35535128 |
Maryam Changizi1, Leila Ghahremani1, Niloofar Ahmadloo2, Mohammad Hossein Kaveh1.
Abstract
Background: Providing better care and encouraging behaviors promoting health are effective measures to manage breast cancer patients. The present research was conducted to carry out an intervention based on the PHE model to promote physical activity, distress management, social support, and quality of life in breast cancer patients.Entities:
Year: 2022 PMID: 35535128 PMCID: PMC9078844 DOI: 10.1155/2022/1944852
Source DB: PubMed Journal: Int J Breast Cancer ISSN: 2090-3189
Figure 1The Patient Health Engagement Model (PHE). Serena Barello, Guendalina Graffigna 2015.
Figure 2Study concert diagram.
Demographic characteristics of patients in the intervention and control groups.
| Variable | Group 1∗ | Group 2∗∗ |
| |||
|---|---|---|---|---|---|---|
| Percent | Frequency | Percent | Frequency | |||
| Job | Self-employed | 7 | 11.4 | 16 | 25.8 |
|
| Retired | 3 | 4.91 | 9 | 14.5 | ||
| Employee | 3 | 4.91 | 19 | 30.6 | ||
| Housewife | 51 | 83.60 | 18 | 29.5 | ||
|
| ||||||
| Education | Academic | 17 | 27.9 | 16 | 25.8 |
|
| Diploma | 17 | 27.9 | 9 | 14.5 | ||
| High school | 15 | 24.6 | 19 | 30.6 | ||
| Primary | 12 | 19.7 | 18 | 29 | ||
|
| ||||||
| Marital status | Single | 54 | 88.5 | 53 | 85.5 |
|
| Married | 7 | 11.4 | 9 | 14.5 | ||
∗Group 1 = intervention, ∗∗group 2 = control, Chi-square test.
PHE scale score changes after the intervention in the group 1 and group 2.
| Variable | Group 1∗ | Group 2∗∗ | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Item 1 | Item 2 | Item 3 | Item 4 | Item 5 | Item 1 | Item 2 | Item 3 | Item 4 | Item 5 | |
| After intervention | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 2 | 2 | 2 |
∗Group 1 = intervention, ∗∗group 2 = control, Descriptive test-median.
Comparison of mean score of physical activity, self-efficacy, distress management, and social support in both groups before and after the intervention.
| Variable | Group 1 ( | |||||||
|---|---|---|---|---|---|---|---|---|
| Physical activity | Self-efficacy | Distress management | Social support | |||||
| Group 1∗ | Group 2∗∗ | Group 1 | Group 2 | Group 1 | Group 2 | Group 1 | Group 2 | |
| Before intervention | 1594 ± 108.1 | 1600 ± 966.6 | 84.5 ± 9.3 | 82.2 ± 8.7 | 3.6 ± 2.5 | 3.67 ± 2.92 | 52.4 ± 9.5 | 51.3 ± 8.7 |
| After intervention | 1950 ± 1031 | 1591.6 ± 956.7 | 97.2 ± 8.5 | 81.8 ± 8.2 | 2.4 ± 2.02 | 3.61 ± 2.87 | 56.7 ± 8.3 | 50.6 ± 8.8 |
| 3 months after | 1950.3 ± 104.3 | 1591.9 ± 958.6 | 97.3 ± 8.1 | 81.7 ± 8.3 | 2.2 ± 1.8 | 3.51 ± 2.73 | 55.8 ± 7.7 | 50.5 ± 8.4 |
|
|
|
|
|
|
|
|
|
|
∗Group 1 = intervention, ∗∗group 2 = control, Friedman test.
Comparison of quality of life score in intervention and control groups.
| Variable | Group 1 ( | |||||
|---|---|---|---|---|---|---|
| Before intervention |
| 3 months after intervention |
| |||
| Group 1 | Group 2 | Group 1 | Group 2 | |||
| Total quality of life | 193.2 ± 14.4 | 194.1 ± 13.1 | < 0.001 | 203.01 ± 8.96 | 194.41 ± 12.2 | 0.675 |
| Physical function | 18.04 ± 2.22 | 18.08 ± 2.08 |
| 18.37 ± 1.41 | 18.08 ± 2.08 | 0.043 |
| Role performance | 7.62 ± 0.859 | 7.56 ± 0.951 |
| 7.92 ± 0.30 | 7.59 ± 0.93 | 0.01 |
| Emotional function | 14.44 ± 1.97 | 14.48 ± 1.96 | 0.908 | 15.19 ± 1.48 | 14.51 ± 1.80 | 0.024 |
| Cognitive function | 7.40 ± 0.901 | 7.25 ± 1.12 | 0.412 | 7.80 ± 0.60 | 7.43 ± 0.822 | 0.005 |
| Social performance | 7.52 ± 0.828 | 7.61 ± 0.732 | 0.532 | 7.85 ± 0.401 | 7.59 ± 0.734 | 0.018 |
| Global health | 6.01 ± 2.68 | 5.91 ± 2.66 | 0.846 | 7.2 ± 2.38 | 5.95 ± 2.60 | 0.005 |
| Body image | 13.18 ± 3.40 | 13.43 ± 3.88 | 0.634 | 14.44 ± 2.42 | 13.46 ± 2.78 | 0.04 |
| Side effects of treatment | 24.77 ± 4.34 | 25.04 ± 4.22 | 0.720 | 26.54 ± 2.49 | 25.17 ± 4.14 | 0.029 |
| Future perspective | 2.16 ± 4.34 | 2.91 ± 0.91 | 0.760 | 3.52 ± 0.622 | 2.93 ± 0.865 | < 0.001 |
| Breast symptom | 15.54 ± 1.009 | 15.93 ± 0.30 | < 0.001 | 15.59 ± 0.948 | 15.62 ± 0.853 | 0.842 |
| Arm symptoms | 11.06 ± 1.28 | 11.16 ± 1.25 | 0.889 | 11.09.81 ± 1.30 | 11.11 ± 1.22 | 0.884 |
| Hair loss | 3.62 ± 0.839 | 3.66 ± 0.767 | 0.106 | 3.96 ± 0.179 | 3.69 ± 0.737 | 0.781 |
| Economic performance | 3.04 ± 0.825 | 3.04 ± 0.818 | 0.908 | 3.09 ± 0.794 | 3.09 ± 0.824 | 0.742 |
| Signs and symptoms of cancer | 48.11 ± 4.66 | 48.32 ± 4.48 | 0.802 | 49.37 ± 3.2 | 48.37 ± 4.50 | 0.159 |
| Sexual function | 9.81 ± 1.96 | 9.85 ± 1.98 | 0.921 | 9.87 ± 2.003 | 10.29 ± 2.18 | 0.264 |
Group 1 = intervention, group 2 = control, Mann–Whitney U test.